Drugs / Rinsulin NPH
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT04012775 | Apr 2017 → Sep 2018 | type 2 diabetes mellitus | Geropharm | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT04501250 | Oct 2017 → Jan 2018 | — | Geropharm | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rinsulin NPH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04501250 ↗ |